Please ensure Javascript is enabled for purposes of website accessibility

Alphabet Unit Developing Coronavirus Triage Tool

By Eric Volkman - Mar 14, 2020 at 11:15AM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Verily provided little detail on its efforts to help defeat the current global health scourge; a tweet disseminated on its behalf seemed more an effort to correct a presidential misstatement.

Verily, the life sciences division of tech giant Alphabet (GOOG 2.87%) (GOOGL 2.82%), said today it is part of the effort to combat the COVID-19 respiratory disease caused by the SARS-CoV-2 coronavirus spreading around the world. 

On Friday, Verily issued a tweet that was disseminated on the feed of fellow Alphabet unit Google Communications. Verily said that "[w]e are developing a tool to help triage individuals for COVID-19 testing. Verily is in the early stages of development, and planning to roll testing out in the Bay Area, with the hope of expanding more broadly over time."

Verily spokeswoman Carolyn Wang, quoted by CNN, said that "[w]hat we're building is a triage tool that will live on ProjectBaseline.com, and we plan to pilot it in California next week."

ProjectBaseline.com is a research project headed by Verily in collaboration with Stanford and Duke Universities and the American Heart Association. It is aimed at "collaborating to build the next generation of healthcare tools and services," as stated on the home page.

A coronavirus colony.

Image source: Getty Images

It seems that Verily's statements were moves to correct remarks made at a White House press conference by president Donald Trump. On Friday, Trump claimed that "Google is helping to develop a website. It's going to be very quickly done, unlike websites of the past, to determine whether a test is warranted and to facilitate testing at a nearby convenient location."

Alphabet, as the parent company, has not rebutted this assertion; it seems Verily's communication was aimed at indirectly doing so.

Regardless, high-visibility tech stock Alphabet was a winner on Friday. The prices of both its publicly traded share classes rose by over 9% on the day.

 

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

Alphabet Inc. Stock Quote
Alphabet Inc.
GOOGL
$2,355.96 (2.82%) $64.52
Alphabet Inc. Stock Quote
Alphabet Inc.
GOOG
$2,370.43 (2.87%) $66.16

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
322%
 
S&P 500 Returns
113%

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 07/07/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.